Pharmacy

Below are five of the top pharmacy stories published by Becker's Hospital Review in November, beginning with the most popular:

Larry Corey, MD, co-founder of Juno Therapeutics, may soon launch another drug company, according to STAT. 

The worsening shortage of a bladder cancer drug solely manufactured by Merck has undoubtedly led to deaths, Pittsburgh urologist Ben Davies, MD, told CNBC.  

A Pennsylvania woman is suing Philadelphia-based pharmacy SunRay Drugs accused of exposing her HIV status to her neighbors, according to the Advocate. 

A federal judge has overturned a portion of the convictions against former Insys Therapeutics executives, saying prosecutors failed to prove they violated the Controlled Substances Act, according to NPR. 

Seven drugs and medical devices approved by the FDA since Nov. 21:

At least six drug companies have received grand jury subpoenas for a federal investigation into whether they fueled the opioid epidemic, people familiar with the matter told The Wall Street Journal.

The FDA has approved Global Blood Therapeutics' drug, Oxbryta, designed to treat sickle cell disease in patients 12 years and older. 

Though drugmakers often claim their prices are based on the cost of a drug's research and development, a report published Nov. 25 in Neurology suggests corporate growth objectives and competition are what actually drive costs for multiple sclerosis drugs, according…

Hospital pharmacies saw the costliest claims filed between 2012 and 2016, according to a new report from two professional liability insurers.